Dual-targeted therapy in HER2-positive breast cancer cells with the combination of carbon dots/HER3 siRNA and trastuzumab

Dual-targeted therapy in HER2-positive breast cancer cells with the combination of carbon dots/HER3 siRNA and trastuzumab resulted in enhanced antitumor activity, which overcomes the resistance to trastuzumab monotherapy. Herein, we have developed branched polyethylenimine-functionalized carbon dot...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Nanotechnology 2020-08, Vol.31 (33), p.335102-335102
Hauptverfasser:	Shu, Mengjun, Gao, Feng, Yu, Chulang, Zeng, Min, He, Guili, Wu, Yan, Su, Yanjie, Hu, Nantao, Zhou, Zhihua, Yang, Zhi, Xu, Lin
Format:	Artikel
Sprache:	eng
Schlagworte:	breast cancer carbon dots gene therapy HER2 resistance trastuzumab
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!